The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
Table 2
Changes in overactive bladder symptoms by previous anticholinergic agent and by gender.
Variables
Overactive bladder symptom scores
Baseline
4 weeks
12 weeks
P-value(2)
Solifenacin ()
(1)
**
**
Tolterodine ()
**
*
Imidafenacin ()
**
**
Male ()
**
**
Female ()
**
**
(1)Mean ± standard deviation. (2)Comparison among groups (combined analysis model).
*
, ** (versus baseline, paired t-test).